Anzen Industries
London, UK· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A biotech company engineering advanced delivery platforms to enhance the efficacy and safety of cell and gene therapies.
OncologyRare Diseases
Technology Platform
Develops novel biomaterial and nanoparticle-based delivery systems designed to improve the targeting, safety, and manufacturability of cell and gene therapies.
Opportunities
A successful, versatile delivery platform could become a foundational technology for multiple partners in the booming cell and gene therapy sector.
Risk Factors
Technical risk of developing a delivery system that is both superior to existing methods and can be reliably manufactured at scale.
Competitive Landscape
Enters a competitive but high-need niche, competing with both academic spin-offs and established drug delivery companies.